Saroja Pharma Industries India Limited — Others, 19-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Saroja Pharma Industries has submitted a Confirmation Certificate for the quarter ended 31st March 2025, as required by SEBI regulations. This certificate confirms the details of securities dematerialized and rematerialized during the reporting period, indicating compliance with operational standards in share management.

The completion of this certification process underlines the company's commitment to transparency and governance. For investors, this reflects a stable operational framework, reducing potential risks related to share management. Overall, this could foster a positive outlook, reinforcing investor confidence in the company’s adherence to regulatory norms.